Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Mela Sciences panel delay: FDA has postponed advisory committee review of Mela Sciences' MelaFind, a non-invasive computer vision system to aid in the detection of melanoma, from Aug. 26 to sometime in November. FDA told the firm it needs more time to arrange the meeting, the firm said July 21 (1"The Gray Sheet" June 28, 2010)